Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.
More than 20,000 professionals from the world of pharmacy return to Las Vegas, Nevada, this weekend for the American Society of Health-System Pharmacists (ASHP) 2022 Midyear Clinical Meeting & Exposition.
Because of the COVID-19 pandemic, the last 2 years have been virtual; the organization previously met in Las Vegas in 2019 and 2016.
Running until Thursday, November 8, the meeting features dozens of topics spanning clinical topics and therapeutics, specialty pharmacy, biosimilars, emergency medicine, infectious diseases, technology, home care, and more.
In addition, many sessions zero in on topics that deal heavily with the day-to-day lives of pharmacists and others working in the current health care climate, such as:
Another track focuses on various topics related to diversity, equity, and inclusion. Sessions encompass supporting those who identify as lesbian, gay, bisexual, transgender, or queer; patients who are disabled; communication strategies for more inclusive work environments; and the dangers of oversimplifying race in clinical practice.
During the meeting, Angela M. Hill, PharmD, CPh, RPh, professor and associate dean of clinical affairs; project director, WE-CARE, University of South Florida Taneja College of Pharmacy, will receive a joint leadership award from ASHP as well as the Association for Black Health-System Pharmacists for her work in addressing health equities.
Another award is being given to Marie A. Chisholm-Burns, PharmD, PhD, MPH, MBA, FCCP, FASHP, FAST, executive vice president and provost at Oregon Health and Science University. She will receive the ASHP Board of Directors’ Distinguished Leadership Award for her work in pharmacy practice leadership and academic pharmacy.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Areas of Unmet Need Continue to Burden Patients With gMG
April 2nd 2025Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those treating and being treated for the chronic autoimmune neuromuscular disorder, to have a more nuanced understanding of experiences and difficulties.
Read More